Literature DB >> 18758299

3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).

Sai Yendamuri1, Ara A Vaporciyan, Tanweer Zaidi, Lei Feng, Ricardo Fernandez, Nebiyou B Bekele, Wayne L Hofstetter, Feng Jiang, Reza J Mehran, David C Rice, Margaret R Spitz, Stephen G Swisher, Garrett L Walsh, Jack A Roth, Ruth L Katz.   

Abstract

BACKGROUND: Our objective was to study the feasibility of detecting chromosomal deletions at 3p22.1 and 10q22.3 by fluorescent in situ hybridization (FISH) and to examine their distribution in different areas of the airway in patients with non-small cell lung cancer.
METHODS: Brush biopsies from the mainstem bronchus on the normal side contralateral to the tumor (NBB) and mainstem bronchus on the tumor side (TBB) were obtained from 122 patients who underwent surgical resection. Touch preparations from the tumor (TTP), normal lung parenchyma, and bronchi adjacent to the tumor were also obtained. Two FISH assays using probes complementary to 3p22.1 and 10q22.3 were used to detect deletions.
RESULTS: NBB showed a relatively low deletion rate of 3p22.1 and 10q22.3 compared with TTP (p < 0.0001). TBB showed a significantly higher rate of deletions compared with NBB but lower than TTP from the tumor (p < 0.05) for both 3p22.1 and 10q22.3. A significantly higher deletion rate was seen at TTP compared with normal lung parenchyma at both the 3p22.1 and 10 q22.3 (p < 0.0001). Correlations were seen between the deletion rates of TTP and TBB at 3p22.1 (rho = 0.61, p < 0.0001) and between TTP and bronchi adjacent to the tumor at 10q22.3 (rho = 0.64, p < 0.0001).
CONCLUSION: Deletions of the 3p22.1 and 10q22.3 regions can be reliably detected by FISH. As one progresses from the contralateral normal bronchus to the bronchus on the side of tumor and the tumor itself, the percentage of chromosomal deletions increases in a statistically significant fashion. This suggests that, FISH analysis of bronchoscopic brushes may be useful for identifying patients at high risk for developing non-small cell lung cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18758299      PMCID: PMC3370669          DOI: 10.1097/JTO.0b013e3181834f3a

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  23 in total

1.  Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer.

Authors:  Marileila Varella-Garcia; John Kittelson; Aline P Schulte; Kieu O Vu; Holly J Wolf; Chan Zeng; Fred R Hirsch; Tim Byers; Tim Kennedy; York E Miller; Robert L Keith; Wilbur A Franklin
Journal:  Cancer Detect Prev       Date:  2004

2.  Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy.

Authors:  S Lam; T Kennedy; M Unger; Y E Miller; D Gelmont; V Rusch; B Gipe; D Howard; J C LeRiche; A Coldman; A F Gazdar
Journal:  Chest       Date:  1998-03       Impact factor: 9.410

3.  Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line.

Authors:  M A O'Reilly; A F Gazdar; R E Morris; J A Whitsett
Journal:  Biochim Biophys Acta       Date:  1988-06-30

4.  Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology.

Authors:  Spasenija Savic; Katharina Glatz; René Schoenegg; Peter Spieler; Georg Feichter; Michael Tamm; Lukas Bubendorf
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

5.  Some results of screening for early lung cancer.

Authors:  W F Taylor; R S Fontana; M A Uhlenhopp; C S Davis
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

Review 6.  How many tumor suppressor genes are involved in human lung carcinogenesis?

Authors:  T Kohno; J Yokota
Journal:  Carcinogenesis       Date:  1999-08       Impact factor: 4.944

7.  Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations.

Authors:  Güliz A Barkan; Nancy P Caraway; Feng Jiang; Tanweer M Zaidi; Ricardo Fernandez; Ara Vaporcyin; Rodolfo Morice; Xian Zhou; Benjamin Nebiyou Bekele; Ruth L Katz
Journal:  Cancer       Date:  2005-02-25       Impact factor: 6.860

8.  Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.

Authors:  Isao Ito; Lin Ji; Fumihiro Tanaka; Yuji Saito; Began Gopalan; Cynthia D Branch; Kai Xu; E Neely Atkinson; Benjamin N Bekele; L Clifton Stephens; John D Minna; Jack A Roth; Rajagopal Ramesh
Journal:  Cancer Gene Ther       Date:  2004-11       Impact factor: 5.987

9.  Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer.

Authors:  Feng Jiang; Nancy P Caraway; Benjamin Nebiyou Bekele; Hua-Zhong Zhang; Abha Khanna; Huijun Wang; Ruiyun Li; Ricardo L Fernandez; Tanweer M Zaidi; Dennis A Johnston; Ruth L Katz
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

10.  Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.

Authors:  Feng Jiang; Zhengnan Yin; Nancy P Caraway; Ruiyun Li; Ruth L Katz
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

View more
  9 in total

1.  A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens.

Authors:  Yi-Zhen Liu; Zhen Wang; Li-Li Fang; Lu Li; Jian Cao; Xin Xu; Ya-Ling Han; Yan Cai; Liang-Xu Wang; Ming-Rong Wang
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-27       Impact factor: 4.553

2.  Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.

Authors:  Lingmin Hu; Chen Wu; Xueying Zhao; Rebecca Heist; Li Su; Yang Zhao; Baohui Han; Songyu Cao; Minjie Chu; Juncheng Dai; Jing Dong; Yongqian Shu; Lin Xu; Yijiang Chen; Yi Wang; Feng Lu; Yue Jiang; Dianke Yu; Hongyan Chen; Wen Tan; Hongxia Ma; Jiaping Chen; Guangfu Jin; Tangchun Wu; Daru Lu; David C Christiani; Dongxin Lin; Zhibin Hu; Hongbing Shen
Journal:  Clin Cancer Res       Date:  2012-08-07       Impact factor: 12.531

3.  Ex vivo chemical cytometric analysis of protein tyrosine phosphatase activity in single human airway epithelial cells.

Authors:  Ryan M Phillips; Lisa A Dailey; Eric Bair; James M Samet; Nancy L Allbritton
Journal:  Anal Chem       Date:  2013-12-31       Impact factor: 6.986

4.  Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study.

Authors:  Ruth L Katz; Weigong He; Abha Khanna; Ricardo L Fernandez; Tanweer M Zaidi; Matthew Krebs; Nancy P Caraway; Hua-Zhong Zhang; Feng Jiang; Margaret R Spitz; David P Blowers; Carlos A Jimenez; Reza J Mehran; Stephen G Swisher; Jack A Roth; Jeffrey S Morris; Carol J Etzel; Randa El-Zein
Journal:  Clin Cancer Res       Date:  2010-07-22       Impact factor: 12.531

5.  Measurement of protein tyrosine phosphatase activity in single cells by capillary electrophoresis.

Authors:  Ryan M Phillips; Eric Bair; David S Lawrence; Christopher E Sims; Nancy L Allbritton
Journal:  Anal Chem       Date:  2013-05-30       Impact factor: 6.986

Review 6.  Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Serge Patrick Nana-Sinkam; Charles A Powell
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

7.  Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer.

Authors:  Mingxiang Feng; Xin Ye; Baishen Chen; Juncheng Zhang; Chuoji Huang; Chunxue Bai; Miao Lin; Haining Zhou; Meng Huang; Yanci Chen; Yunhe Zhu; Botao Xiao; Ruth L Katz
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-06       Impact factor: 4.553

8.  FANCJ is essential to maintain microsatellite structure genome-wide during replication stress.

Authors:  Joanna Barthelemy; Helmut Hanenberg; Michael Leffak
Journal:  Nucleic Acids Res       Date:  2016-05-13       Impact factor: 16.971

9.  Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.

Authors:  Han Yang; Hongjie Chen; Guorui Zhang; Hongyi Li; Ran Ni; Yali Yu; Yepeng Zhang; Yongjun Wu; Hong Liu
Journal:  BMC Cancer       Date:  2022-04-09       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.